Categories Earnings, Health Care
Johnson & Johnson (JNJ) beats Q4 earnings estimates, misses on revenue
Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations. The shares were down 1.5% in premarket hours on Wednesday.
Total revenue of $20.7 billion inched up 1.7% from the same period last year, but came slightly below consensus forecasts of $20.8 billion. Adjusted operational sales, which excludes impacts from acquisitions, divestitures and currency translations, increased 3.4%.
![Johnson & Johnson reports Q4 2019 earnings results](https://cdn.news.alphastreet.com/wp-content/uploads/2020/01/Johnson-Johnson-Q4-2019-Earnings-Infographic.jpg)
GAAP net income grew 31.8% to $4 billion and EPS improved around 34% to $1.50. Adjusted net income fell 6.4% year-over-year to $5 billion. Adjusted EPS dropped 4.6% to $1.88 but beat estimates of $1.87.
Alex Gorsky, Chairman and CEO stated, “We delivered strong underlying sales and earnings growth in 2019, driven by the strength of our Pharmaceutical business, accelerating performance in our Medical Devices business and improved profitability in our Consumer business.”
Sales in the US increased 1.4% to $10.7 billion while international sales rose 2.1% to $9.9 billion. The Consumer and Pharmaceutical segments saw sales increases of 0.9% and 3.5% respectively, while sales in the Medical Devices segment was down 0.5%.
For the full year of 2020, the company expects reported sales to grow 4-5% to $85.4 billion to $86.2 billion. Operational sales are expected to grow 4.5-5.5% to $85.8-$86.6 billion. Adjusted operational sales are expected to grow 5-6%.
Adjusted EPS is expected to increase 3.1-4.8% to a range of $8.95-9.10 and adjusted operational EPS is expected to rise 3.7-5.4% to a range of $9.00-9.15.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%